An advertisement for mentor (fentanyl buccal tablet) for opioid-tolerant adult patients with cancer. The background of the image is green and the text is in white. The text is divided into two sections. On the left side there is a red arrow pointing upwards indicating that the tablet is approved for use since 2006. On the right side it is written in black text. Below the arrow there are two bullet points that explain the benefits of the tablet. The first bullet point states that mentors is an indicator for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are concerned about the spread of the disease. The second bullet point explains that the tablets are not used in opioid treatment and that they are not available for use in the treatment of cancer patients. The third bullet point mentions that the product may not be used in a variety of conditions such as pain inflammation and inflammation. The fourth bullet point emphasizes that the FDA is not responsible for the use of the medication and that it may be used to treat the condition.

• Advertisement

• Sales and Marketing